L, Y., Q, L., C, T., X, W., X, L., Y, L., . . . X, Z. Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
Chicago Style (17th ed.) CitationL, Yi, Liu Q, Tan C, Wan X, Luo X, Li Y, Li H, and Zeng X. Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
MLA (9th ed.) CitationL, Yi, et al. Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma. Dove Medical Press.
Warning: These citations may not always be 100% accurate.